New Key Statistics Module, Z-Score and F-Score
SZSE:002750 Key Ratios
Market Cap ¥ M | 1,217.52 |
Enterprise Value ¥ M | 890.19 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.39 |
Price/Sales | 13.33 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 91.00 |
EPS (TTM) ¥ | -0.17 |
Beneish M-Score | -2.78 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -15.04 |
EV-to-EBITDA | -15.04 |
PEG | -- |
Shares Outstanding M | 400.50 |
Net Margin (%) | -73.61 |
Operating Margin % | -64.04 |
Pre-tax Margin (%) | -86.96 |
Quick Ratio | 5.57 |
Current Ratio | 5.97 |
ROA % (ttm) | -10.08 |
ROE % (ttm) | -12.38 |
ROIC % (ttm) | -21.85 |
Dividend Yield % | -- |
Altman Z-Score | 8.02 |
SZSE:002750 Number of Guru Trades
SZSE:002750 Volume of Guru Trades
Gurus Latest Trades with SZSE:002750
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002750 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Kunming Longjin Pharmaceutical Co Ltd Insider Transactions
No Available Data